SSKN · STRATA Skin Sciences, Inc.

Options to Purchase 10,000 option shares shall vest on each of May 13, 2026, May 13, 2027, May 13, 2028 and May 13, 2029.

Ownership figures prior to the date hereof have been adjusted to reflect the 10 for 1 reverse stock split effected by the Company on June 6, 2024.

Options to Purchase 7,500 option shares shall vest on each of May 13, 2026, May 13, 2027, May 13, 2028 and May 13, 2029.

Options to Purchase 14,500 option shares shall vest on each of May 13, 2026, May 13, 2027, May 13, 2028 and May 13, 2029.

Ownership figures prior to the date hereof have been adjusted to reflect the 10 for 1 reverse stock split effected by the Company on June 6, 2024.

Shares are held directly by Accelmed Partners, L.P. The reporting person is the controlling member and managing partner of Accelmed Growth Partners (AGP) Limited, which is the general partner of Accelmed Partners (GP), L.P., which is the general partner of Accelmed Partners, L.P. and as a result he may be deemed to beneficially own the shares of common stock held by Accelmed Partners, L.P. The reporting person is the controlling shareholder and managing partner of Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares of common stock owned by Accelmed Partners, L.P. pursuant to a management agreement, and as a result the reporting person may be deemed to beneficially own the shares of the common stock held by Accelmed Partners, L.P. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Options shall vest in twelve equal quarterly amounts over a period of three years from date of grant.

Options shall vest in twelve equal quarterly amounts over a period of three years from the date of grant.

Options to purchase 145,465 Option Shares shall vest on January 30, 2024; and Options to purchase 145,464 Option Shares shall vest on each of April 30, 2024, July 30, 2024, October 30, 2024, January 30, 2025, April 30, 2025, July 30, 2025, October 30, 2025, January 30, 2026, April 30, 2026, July 30, 2026, and October 30 2026.

This Form 4 is filed jointly by 22NW Fund, LP ("22NW Fund"), 22NW, LP ("22NW"), 22NW Fund GP, LLC ("22NW GP"), 22NW GP, Inc. ("22NW Inc.") and Aron R. English (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4799 to $0.5600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Securities owned directly by 22NW Fund. As the investment manager to 22NW Fund, 22NW may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW Fund, 22NW GP may be deemed to beneficially own the securities owned directly by 22NW Fund. As the general partner of 22NW, 22NW Inc. may be deemed to beneficially own the securities owned directly by 22NW Fund. Mr. English, as the Portfolio Manager of 22NW, Manager of 22NW GP and President and sole shareholder of 22NW Inc., may be deemed to beneficially own the securities owned directly by 22NW Fund.

Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on July 5, 2023, utilizing the closing price on July 3, 2023. The Restricted Stock will vest at 100%, in equal quarterly installments, over a 12 month period.

Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on July 5, 2023, utilizing the closing price on July 3, 2023. The Restricted Stock will vest at 100%, in equal quarterly installments, over a 12 month period.

Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on July 5, 2023, utilizing the closing price on July 3, 2023. The Restricted Stock will vest at 100%, in equal quarterly installments, over a 12 month period.

Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on July 5, 2023, utilizing the closing price on July 3, 2023. The Restricted Stock will vest at 100%, in equal quarterly installments, over a 12 month period.

Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on July 5, 2023, utilizing the closing price on July 3, 2023. The Restricted Stock will vest at 100%, in equal quarterly installments, over a 12 month period.

Options shall vest in four equal installments over a four year period on each of the following dates: March 30, 2023, March 30, 2024, March 30, 2025 and on March 30, 2026.

Vesting of these options depends upon the Company's achieving a targeted stock price as set on the date of grant by the Compensation Committee. The target must be achieved by December 31, 2023 or the options lapse.

Options shall vest in four equal installments over a four year period on each of the following dates: March 30, 2023, March 30, 2024, March 30, 2025 and on March 30, 2026.

Options shall vest in four equal installments over a four year period on each of the following dates: March 30, 2023, March 30, 2024, March 30, 2025 and on March 30, 2026.

Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on July 1, 2022. The Restricted Stock Units will vest at 100%, in equal quarterly installments, over a 12 month period.

Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on July 1, 2022. The Restricted Stock Units will vest at 100%, in equal quarterly installments, over a 12 month period.

Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on July 1, 2022. The Restricted Stock Units will vest at 100%, in equal quarterly installments, over a 12 month period.

Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on July 1, 2022. The Restricted Stock Units will vest at 100%, in equal quarterly installments, over a 12 month period.

Represents Restricted Stock Units issued to recipient in lieu of a portion of the recipient's Board Compensation on June 30, 2022. The Restricted Stock will vest at 100% upon issue.

Represents Restricted Stock Units issued to the recipient in lieu of a portion of the recipient's Board Compensation on June 30, 2022. The Restricted Stock Units vest at 100% upon issue.

23,131 shares of common stock purchased over the course of the day, at an average price of $1.12.